SUPERCOMPUTERS HELP GET A GRIP ON AIDS

July 21, 2000

by Michael Schneider

Pittsburgh, PA. — Although AIDS awareness programs and research leading to powerful drugs such as AZT have reduced AIDS-related mortality, AIDS remains one of the most pressing U.S. public-health problems, with incidence rising in some areas and population groups. In less developed parts of the world, furthermore, AIDS is virtually out of control. In South Africa, AIDS infects a third of the current populace of 43 million, compared to under 1 percent here, and is the leading cause of death, with no abatement in sight.

Because of their high cost, the drug “cocktails” that control HIV, the virus that causes AIDS, have been of little use in Africa. Even at their most successful, furthermore, these drugs aren’t a cure-all. By retarding HIV’s ability to reproduce in humans, they save many lives, but the quest for AIDS researchers remains, as it has been, to find a cure – not just therapeutic agents that manage the disease, but a knockout punch.

Physicist Marcela Madrid of the Pittsburgh Supercomputing Center and Carnegie Mellon biologist Jonathan Lukin are contributing to this effort. Their computer simulations have revealed new understanding of an enzyme, HIV-1 reverse transcriptase (RT), that enters the body in the package of proteins and ribonucleic acid that comprise HIV. RT plays an essential role in reproducing the virus and because of this is an important target for drugs.

Madrid specializes in simulating biological molecules, and in 1998-99 she began collaborating on RT with a team of structural biologists. Because RT is a very large molecule, about 1,000 amino-acids, it hadn’t been simulated before, and Madrid’s effort, using PSC’s CRAY T3E, broke new ground. By providing a moving picture of RT, her work filled in details unavailable from the molecule’s static structure. Beyond this, her results went a long way toward showing that this kind of computer simulation, called molecular dynamics, can be a valuable partner with laboratory studies in furthering AIDS research.

With these simulations as groundwork, Madrid and Lukin this year took the next step: including water molecules that surround RT in the living cellular environment. This greatly expanded the computational demands of the project, challenging memory limitations of PSC’s CRAY T3E, and Madrid turned to the SGI Origin 2000 at the National Computational Science Alliance in Illinois. Their results from this recent work, which also relied partly on PSC’s Intel Cluster, offer fresh insight into the details of how this enzyme interacts with other molecules to reproduce the virus.

Like many viruses, HIV carries its genetic information as RNA, which is single-stranded and must be converted to double-stranded DNA before the virus can reproduce. This is where RT comes into play. The enzyme takes its name, reverse transcriptase, from what it does: It transcribes the RNA bases and one-at-a-time creates a complementary base to form the DNA version of HIV’s genome, from which it then creates a mirror-image strand and pastes them together to form the DNA double-helix. It’s “reverse” transcription because in most cells transcription goes the other direction – DNA to RNA. To some extent, this RT copy-and-paste process is understood, and to some extent it’s a mystery – especially the fine-grained details of the molecular manipulations.

What’s clear is if you find a foolproof way to stop RT from doing its job you will have cured AIDS. Several existing AIDS drugs work by binding to RT and blocking transcription. These therapies are less than fully effective, however, because HIV transcription is highly prone to error, giving the virus a protean ability to mutate and, thereby, to defeat drugs. It’s estimated that HIV can undergo as much genetic change in 10 years as the human species does over millions of years.

For this reason especially, researchers want to delineate the atom-by-atom picture of how RT transcribes RNA to DNA. A major step in this direction, and in AIDS research in general since the late 80s, has been to deduce the static structure of RT using x-ray crystallography. This work shows that the active domain of RT, where transcription takes place, is analogous to a hand, with subdomains that roughly represent a thumb, fingers and palm. Interestingly, two versions of this structure – one bound with DNA, one not – show a big difference: With DNA, the thumb is extended and open, making space for the DNA to fit into the palm; without DNA, the thumb is folded over to almost touch the fingers.

This difference was Madrid’s entry to HIV research. Her CRAY T3E simulations at PSC last year investigated whether removing the DNA from the open-thumb structure would cause the thumb to close. It did. Her molecular dynamics movie showed the open thumb closing to a position that agrees well with the closed-thumb crystal structure, indicating that closed thumb is the low-energy, “native-state” of RT. These simulations, furthermore, support thinking that RT’s movable thumb may be a key to the transcription process, allowing the enzyme to slide along the RNA strand as it adds bases one-by-one to form DNA.

Along with possibly being involved in transcription, the joint-like flexibility of the RT thumb may be a factor in how one class of AIDS drugs inhibits HIV reproduction, since it’s believed that these drugs lodge in the palm of RT and interfere with transcription by locking the thumb in an open position. “We want to understand RT’s flexibility,” says Madrid, “when it’s by itself, when it’s bound with DNA and when it’s bound with drugs.”

With this objective, Madrid and Lukin used the SGI Origin 2000 to simulate RT structures with and without DNA. The plan was to compare the fluctuations of each atom as shown in molecular dynamics movies to the crystal structures, which are derived by methods that deduce atomic position according to electron density, and therefore include a measure – called the crystallographic B-factor – that represents the uncertainty in the position of an atom, evidence for motion.

By adding 37,000 water molecules to immerse the RT molecule in a water bath, these simulations had a degree of realism missing from the prior study. The simulation with DNA included more than 130,000 atoms, a huge number for this kind of computation. For each of the two structures, the researchers simulated a nanosecond (billionth of a second) of dynamics, recording the atomic coordinates every half picosecond (trillionth of a second). To do this, they used 32 SGI Origin processors, with each computation requiring about 600 hours of computing.

For the structure without DNA, the results showed good correlation between the simulations and B-factors, giving confidence in the accuracy of the simulation. For the structure with DNA, the simulation showed greater flexibility in the tips of the thumb and fingers than suggested by the crystal structure, and also more flexibility than the structure without DNA.

This flexibility of the fingertips, says Madrid, is consistent with the difference in fingertip position between the RT crystal structure with DNA and another recently reported RT structure that includes a molecule, deoxynucleoside triphosphate, that elongates the DNA. “The movement in the fingers,” says Madrid, “tends to validate the postulate that the fingers open to let this molecule in and then close to trap it in place.”

This simulation showed, furthermore, that movements in different regions correlate with each other. The thumb and fingers and a binding pocket in the palm are moving at the same time – information that can’t be obtained experimentally. “This is the first time the motion of the whole molecule has been simulated in water,” says Madrid, “and we can see that the whole molecule is moving in a concerted manner.”

Though well short of a complete atomic-level solution to the HIV transcription process, this dynamic, detailed picture complements the crystal structures and pulls together much of the available information into a consistent whole, offering a blueprint for future work. In their next project, Madrid and Lukin plan to simulate RT structures that include drug molecules that inhibit transcription. “We’ll be looking for clues,” says Madrid, “to see how the drugs work.” More information is available at http://www.psc.edu/science/madrid2000.html .

============================================================

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

China’s Tencent Server Design Will Use AMD Rome

November 13, 2019

Tencent, the Chinese cloud giant, said it would use AMD’s newest Epyc processor in its internally-designed server. The design win adds further momentum to AMD’s bid to erode rival Intel Corp.’s dominance of the glo Read more…

By George Leopold

NCSA Industry Conference Recap – Part 1

November 13, 2019

Industry Program Director Brendan McGinty welcomed guests to the annual National Center for Supercomputing Applications (NCSA) Industry Conference, October 8-10, on the University of Illinois campus in Urbana (UIUC). On Read more…

By Elizabeth Leake, STEM-Trek

Cray, Fujitsu Both Bringing Fujitsu A64FX-based Supercomputers to Market in 2020

November 12, 2019

The number of top-tier HPC systems makers has shrunk due to a steady march of M&A activity, but there is increased diversity and choice of processing components with Intel Xeon, AMD Epyc, IBM Power, and Arm server ch Read more…

By Tiffany Trader

Intel AI Summit: New ‘Keem Bay’ Edge VPU, AI Product Roadmap

November 12, 2019

At its AI Summit today in San Francisco, Intel touted a raft of AI training and inference hardware for deployments ranging from cloud to edge and designed to support organizations at various points of their AI journeys. Read more…

By Doug Black

SIA Recognizes Robert Dennard with 2019 Noyce Award

November 12, 2019

If you don’t know what Dennard Scaling is, the chances are strong you don’t labor in electronics. Robert Dennard, longtime IBM researcher, inventor of the DRAM and the fellow for whom Dennard Scaling was named, is th Read more…

By John Russell

AWS Solution Channel

Making High Performance Computing Affordable and Accessible for Small and Medium Businesses with HPC on AWS

High performance computing (HPC) brings a powerful set of tools to a broad range of industries, helping to drive innovation and boost revenue in finance, genomics, oil and gas extraction, and other fields. Read more…

IBM Accelerated Insights

Leveraging Exaflops Performance to Remediate Nuclear Waste

November 12, 2019

Nuclear waste storage sites are a subject of intense controversy and debate; nobody wants the radioactive remnants in their backyard. Now, a collaboration between Berkeley Lab, Pacific Northwest National University (PNNL Read more…

By Oliver Peckham

Cray, Fujitsu Both Bringing Fujitsu A64FX-based Supercomputers to Market in 2020

November 12, 2019

The number of top-tier HPC systems makers has shrunk due to a steady march of M&A activity, but there is increased diversity and choice of processing compon Read more…

By Tiffany Trader

IBM Adds Support for Ion Trap Quantum Technology to Qiskit

November 11, 2019

After years of percolating in the shadow of quantum computing research based on superconducting semiconductors – think IBM, Rigetti, Google, and D-Wave (quant Read more…

By John Russell

Tackling HPC’s Memory and I/O Bottlenecks with On-Node, Non-Volatile RAM

November 8, 2019

On-node, non-volatile memory (NVRAM) is a game-changing technology that can remove many I/O and memory bottlenecks and provide a key enabler for exascale. Th Read more…

By Jan Rowell

MLPerf Releases First Inference Benchmark Results; Nvidia Touts its Showing

November 6, 2019

MLPerf.org, the young AI-benchmarking consortium, today issued the first round of results for its inference test suite. Among organizations with submissions wer Read more…

By John Russell

Azure Cloud First with AMD Epyc Rome Processors

November 6, 2019

At Ignite 2019 this week, Microsoft's Azure cloud team and AMD announced an expansion of their partnership that began in 2017 when Azure debuted Epyc-backed ins Read more…

By Tiffany Trader

Nvidia Launches Credit Card-Sized 21 TOPS Jetson System for Edge Devices

November 6, 2019

Nvidia has launched a new addition to its Jetson product line: a credit card-sized (70x45mm) form factor delivering up to 21 trillion operations/second (TOPS) o Read more…

By Doug Black

In Memoriam: Steve Tuecke, Globus Co-founder

November 4, 2019

HPCwire is deeply saddened to report that Steve Tuecke, longtime scientist at Argonne National Lab and University of Chicago, has passed away at age 52. Tuecke Read more…

By Tiffany Trader

Spending Spree: Hyperscalers Bought $57B of IT in 2018, $10B+ by Google – But Is Cloud on Horizon?

October 31, 2019

Hyperscalers are the masters of the IT universe, gravitational centers of increasing pull in the emerging age of data-driven compute and AI.  In the high-stake Read more…

By Doug Black

Supercomputer-Powered AI Tackles a Key Fusion Energy Challenge

August 7, 2019

Fusion energy is the Holy Grail of the energy world: low-radioactivity, low-waste, zero-carbon, high-output nuclear power that can run on hydrogen or lithium. T Read more…

By Oliver Peckham

Using AI to Solve One of the Most Prevailing Problems in CFD

October 17, 2019

How can artificial intelligence (AI) and high-performance computing (HPC) solve mesh generation, one of the most commonly referenced problems in computational engineering? A new study has set out to answer this question and create an industry-first AI-mesh application... Read more…

By James Sharpe

Cray Wins NNSA-Livermore ‘El Capitan’ Exascale Contract

August 13, 2019

Cray has won the bid to build the first exascale supercomputer for the National Nuclear Security Administration (NNSA) and Lawrence Livermore National Laborator Read more…

By Tiffany Trader

DARPA Looks to Propel Parallelism

September 4, 2019

As Moore’s law runs out of steam, new programming approaches are being pursued with the goal of greater hardware performance with less coding. The Defense Advanced Projects Research Agency is launching a new programming effort aimed at leveraging the benefits of massive distributed parallelism with less sweat. Read more…

By George Leopold

AMD Launches Epyc Rome, First 7nm CPU

August 8, 2019

From a gala event at the Palace of Fine Arts in San Francisco yesterday (Aug. 7), AMD launched its second-generation Epyc Rome x86 chips, based on its 7nm proce Read more…

By Tiffany Trader

D-Wave’s Path to 5000 Qubits; Google’s Quantum Supremacy Claim

September 24, 2019

On the heels of IBM’s quantum news last week come two more quantum items. D-Wave Systems today announced the name of its forthcoming 5000-qubit system, Advantage (yes the name choice isn’t serendipity), at its user conference being held this week in Newport, RI. Read more…

By John Russell

Ayar Labs to Demo Photonics Chiplet in FPGA Package at Hot Chips

August 19, 2019

Silicon startup Ayar Labs continues to gain momentum with its DARPA-backed optical chiplet technology that puts advanced electronics and optics on the same chip Read more…

By Tiffany Trader

Crystal Ball Gazing: IBM’s Vision for the Future of Computing

October 14, 2019

Dario Gil, IBM’s relatively new director of research, painted a intriguing portrait of the future of computing along with a rough idea of how IBM thinks we’ Read more…

By John Russell

Leading Solution Providers

ISC 2019 Virtual Booth Video Tour

CRAY
CRAY
DDN
DDN
DELL EMC
DELL EMC
GOOGLE
GOOGLE
ONE STOP SYSTEMS
ONE STOP SYSTEMS
PANASAS
PANASAS
VERNE GLOBAL
VERNE GLOBAL

Intel Confirms Retreat on Omni-Path

August 1, 2019

Intel Corp.’s plans to make a big splash in the network fabric market for linking HPC and other workloads has apparently belly-flopped. The chipmaker confirmed to us the outlines of an earlier report by the website CRN that it has jettisoned plans for a second-generation version of its Omni-Path interconnect... Read more…

By Staff report

Kubernetes, Containers and HPC

September 19, 2019

Software containers and Kubernetes are important tools for building, deploying, running and managing modern enterprise applications at scale and delivering enterprise software faster and more reliably to the end user — while using resources more efficiently and reducing costs. Read more…

By Daniel Gruber, Burak Yenier and Wolfgang Gentzsch, UberCloud

Dell Ramps Up HPC Testing of AMD Rome Processors

October 21, 2019

Dell Technologies is wading deeper into the AMD-based systems market with a growing evaluation program for the latest Epyc (Rome) microprocessors from AMD. In a Read more…

By John Russell

Rise of NIH’s Biowulf Mirrors the Rise of Computational Biology

July 29, 2019

The story of NIH’s supercomputer Biowulf is fascinating, important, and in many ways representative of the transformation of life sciences and biomedical res Read more…

By John Russell

Intel Debuts Pohoiki Beach, Its 8M Neuron Neuromorphic Development System

July 17, 2019

Neuromorphic computing has received less fanfare of late than quantum computing whose mystery has captured public attention and which seems to have generated mo Read more…

By John Russell

Xilinx vs. Intel: FPGA Market Leaders Launch Server Accelerator Cards

August 6, 2019

The two FPGA market leaders, Intel and Xilinx, both announced new accelerator cards this week designed to handle specialized, compute-intensive workloads and un Read more…

By Doug Black

When Dense Matrix Representations Beat Sparse

September 9, 2019

In our world filled with unintended consequences, it turns out that saving memory space to help deal with GPU limitations, knowing it introduces performance pen Read more…

By James Reinders

With the Help of HPC, Astronomers Prepare to Deflect a Real Asteroid

September 26, 2019

For years, NASA has been running simulations of asteroid impacts to understand the risks (and likelihoods) of asteroids colliding with Earth. Now, NASA and the European Space Agency (ESA) are preparing for the next, crucial step in planetary defense against asteroid impacts: physically deflecting a real asteroid. Read more…

By Oliver Peckham

  • arrow
  • Click Here for More Headlines
  • arrow
Do NOT follow this link or you will be banned from the site!
Share This